These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29450647)

  • 21. What is repeated in ALS and FTLD.
    Fecto F; Siddique T
    Lancet Neurol; 2012 Jan; 11(1):25-7. PubMed ID: 22154784
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72.
    Ishiura H; Tsuji S
    J Neurogenet; 2015; 29(2-3):85-94. PubMed ID: 26540641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
    Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C
    Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of DNA G-quadruplex species forming from C9ORF72 G4C2-expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Šket P; Pohleven J; Kovanda A; Štalekar M; Župunski V; Zalar M; Plavec J; Rogelj B
    Neurobiol Aging; 2015 Feb; 36(2):1091-6. PubMed ID: 25442110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
    Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
    Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
    Millecamps S; De Septenville A; Teyssou E; Daniau M; Camuzat A; Albert M; LeGuern E; Galimberti D; ; Brice A; Marie Y; Le Ber I
    Neurobiol Aging; 2014 Dec; 35(12):2882.e13-2882.e15. PubMed ID: 25158920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis.
    Ciura S; Lattante S; Le Ber I; Latouche M; Tostivint H; Brice A; Kabashi E
    Ann Neurol; 2013 Aug; 74(2):180-7. PubMed ID: 23720273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply: C9orf72 mutations and the puzzle of cerebro-cerebellar network degeneration.
    Guo CC; Hornberger M
    Brain; 2016 Aug; 139(Pt 8):e45. PubMed ID: 27190029
    [No Abstract]   [Full Text] [Related]  

  • 29. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins.
    Mori K; Arzberger T; Grässer FA; Gijselinck I; May S; Rentzsch K; Weng SM; Schludi MH; van der Zee J; Cruts M; Van Broeckhoven C; Kremmer E; Kretzschmar HA; Haass C; Edbauer D
    Acta Neuropathol; 2013 Dec; 126(6):881-93. PubMed ID: 24132570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
    Fenoglio C; De Riz M; Villa C; Serpente M; Ridolfi E; Bonsi R; Cioffi SM; Barone C; Pietroboni A; Calvi A; Scarpini E; Galimberti D
    Neurobiol Aging; 2014 May; 35(5):1213.e1-2. PubMed ID: 24355526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling C9orf72 dipeptide repeat proteins of a physiologically relevant size.
    Bennion Callister J; Ryan S; Sim J; Rollinson S; Pickering-Brown SM
    Hum Mol Genet; 2016 Dec; 25(23):5069-5082. PubMed ID: 27798094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients.
    Jääskeläinen O; Solje E; Hall A; Katisko K; Korhonen V; Tiainen M; Kangas AJ; Helisalmi S; Pikkarainen M; Koivisto A; Hartikainen P; Hiltunen M; Ala-Korpela M; Soininen H; Soininen P; Haapasalo A; Remes AM; Herukka SK
    J Alzheimers Dis; 2019; 72(1):127-137. PubMed ID: 31561355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis.
    Van Damme P; Robberecht W
    Curr Opin Neurol; 2013 Oct; 26(5):466-72. PubMed ID: 23945281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening UBQLN-2 in French frontotemporal lobar degeneration and frontotemporal lobar degeneration-amyotrophic lateral sclerosis patients.
    Lattante S; Le Ber I; Camuzat A; Pariente J; Brice A; Kabashi E;
    Neurobiol Aging; 2013 Aug; 34(8):2078.e5-6. PubMed ID: 23582661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C9orf72 mutations and the puzzle of cerebro-cerebellar network degeneration.
    Marshall CR; Bocchetta M; Rohrer JD; Warren JD
    Brain; 2016 Aug; 139(Pt 8):e44. PubMed ID: 27190011
    [No Abstract]   [Full Text] [Related]  

  • 36. C9ORF72: grabbing a tiger by the tail.
    Mann D
    Acta Neuropathol; 2014 Mar; 127(3):311-8. PubMed ID: 24493409
    [No Abstract]   [Full Text] [Related]  

  • 37. Co-occurrence of the C9ORF72 expansion and a novel GRN mutation in a family with alternative expression of frontotemporal dementia and amyotrophic lateral sclerosis.
    Testi S; Tamburin S; Zanette G; Fabrizi GM
    J Alzheimers Dis; 2015; 44(1):49-56. PubMed ID: 25182743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis.
    Broustal O; Camuzat A; Guillot-Noël L; Guy N; Millecamps S; Deffond D; Lacomblez L; Golfier V; Hannequin D; Salachas F; Camu W; Didic M; Dubois B; Meininger V; Le Ber I; Brice A;
    J Alzheimers Dis; 2010; 22(3):765-9. PubMed ID: 21158017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
    Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
    JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.